arrow
R

Roman Gulati

Fred Hutchinson Cancer Center
H指数:45
被引数:8,516

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Recommendations of the American Cancer Society workshop on design, conduct, analysis, and reporting of multicancer early detection trials with late-stage incidence end points and post-trial ongoing evaluation—The Peachtree Consensus

美国癌症协会关于多癌种早期检测试验的设计、实施、分析和报告(以晚期发病终点和试验后持续评估为对象)的建议——桃树共识

Cancer
IF5.1
2026-09-270
OAAI
Results from a Phase 2 Study of Induction Docetaxel and Carboplatin Followed by Maintenance Rucaparib in the Treatment of Patients with Metastatic Castration-resistant Prostate Cancer with DNA Homologous Recombination Repair Deficiency

多西他赛和卡铂诱导治疗伴DNA同源重组修复缺陷的转移性去势抵抗性前列腺癌患者的2期研究结果

2025-05-230
PRE
Association of Prior PARP Inhibitor Exposure with Clinical Outcomes after 177Lu-PSMA-617 in Men with Castration-resistant Prostate Cancer and Mutations in DNA Homologous Recombination Repair Genes
2025-02-070
PRE
PET-Based TheraP Eligibility and Outcomes of VISION-Eligible Patients with Metastatic Castration-Resistant Prostate Cancer Who Received 177Lu-PSMA-617: Importance of 18F-FDG-Avid Discordant Findings

基于PET的TheraP资格及VISION试验合格患者中接受177Lu-PSMA-617治疗的转移性去势抵抗性前列腺癌患者的结局:18F-FDG显像不一致结果的重要性

2024-11-141
PRE
Assessment of TROP2, CEACAM5 and DLL3 in metastatic prostate cancer: Expression landscape and molecular correlates
2024-05-173
OAAI
The Prostate Cancer Active Lifestyle Study (PALS): A randomized controlled trial of diet and exercise in overweight and obese men on active surveillance

前列腺癌积极生活方式研究 (PALS): 对超重和肥胖男性进行积极监测的饮食和运动的随机对照试验

CANCER
IF5.1
2024-02-141
PRE
Characterization of HOXB13 expression patterns in localized and metastatic castration-resistant prostate cancer
2023-10-189
OA